Please login to the form below

Not currently logged in
Email:
Password:

Werner Wenning set for return to Bayer

He will be joined on the supervisory board by former Novartis Pharma CEO Thomas Ebling

Bayer_Werner_WenningBayer's former chairman and CEO Werner Wenning is set to return to the German pharma company in the Autumn as chairman of its supervisory board.

Wenning was chairman of the company's board of management from 2002 to 2010 and will take over as chairman of the supervisory board from Dr Manfred Schneider in October for a five-year term of office.

Wenning started at Bayer as a trainee and subsequently spent nearly 45 years with the company.

During this time he helped establish Bayer's Peruvian subsidiary, was seconded for a  year to the Treuhandanstalt - the Berlin-based privatisation agency that helped rebuild East Germany's economy after reunification, and served as managing Director of Bayer's largest company in Spain.

Also nominated for election to the supervisory board are two new stockholder representatives: Sue Rataj, who sits on the board of US chemicals company Cabot, and Thomas Ebeling.

Ebling is currently CEO of German media conglomerate ProSiebenSat.1 Media, but served in a series of senior roles at Novartis between 1998 and 2009. These included CEO of its global pharma business and then CEO of its consumer health division.

24th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics